Christopher Horan, Chief Technology Operations Officer at Artiva Biotherapeutics, Inc. (ARTV), sold 10,366 shares at $11.16 ($116K) on 2026-09-03, disclosed to the SEC on 2026-09-04.
Open-market sale of $116k ARTV by Chief Technology Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.